Profile
Mark G.
Osterman — Joined Discovery in June 2004 as Senior Vice President, Sales and Marketing.
Mr. Osterman brings with him over 16 years of industry experience with leading pharmaceutical companies.
Prior to Discovery, Mr. Osterman was at Johnson & Johnson where he served in a variety of positions including Vice President at Johnson & Johnson Development Corporation and Executive Director - Global Biologics Strategic Marketing Group at Centocor, Inc., where he oversaw and built marketing functions for the cardio-pulmonary, metabolism and infectious disease therapeutic areas.
While at Centocor, Mr. Osterman lead the commercial due diligence team in Johnson & Johnson’s acquisition of Scios Inc. Previously, Mr. Osterman was at GlaxoSmithKline, his most senior position being Director, Pulmonary Portfolio - Global Marketing Group where he was involved with the successful launch of several respiratory products including Serevent® for the COPD (Chronic Obstructive Pulmonary Disease) and pediatric indications.
Earlier in his career, Osterman was a product manager, respiratory medical liaison and sales representative.
Mr. Osterman has dual B.A.
degrees in Economics and Business Management from North Carolina State University.
Former positions of Mark G. Osterman
Companies | Position | End |
---|---|---|
WINDTREE THERAPEUTICS, INC. | Sales & Marketing | 2006-04-27 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Corporate Officer/Principal | - |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Director/Board Member | - |
Training of Mark G. Osterman
The University of North Carolina at Charlotte | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
WINDTREE THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Mark G. Osterman